Home › Funds › Ikarian Capital, LLC › ANRO

Ikarian Capital, LLC position in ANRO

ALTO NEUROSCIENCE INC COM SHS · Health Care

Ikarian Capital, LLC reported holding 407,338 shares of ANRO (ALTO NEUROSCIENCE INC COM SHS) in its Q2 2026 13F filing — a position valued at US$10.7M, representing 1.73% of its reported portfolio and ranking #16 among its reported holdings. Ikarian Capital, LLC has disclosed ANRO holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)407.34K sh
Reported value held$10.75M
Portfolio Weight1.73%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ikarian Capital, LLC's ANRO position evolved

Ikarian Capital, LLC first disclosed a stake in ANRO in Q3 2024 at 431,000 shares (US$4.9M). The position peaked in Q1 2026 at 515,000 shares, worth US$11.6M. Across 8 filings, Ikarian Capital, LLC increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 407,338 shares valued at US$10.7M — a reduction of -107,662 shares quarter over quarter.. Notable position changes include a 50% trim in Q1 2025 (shares rose 2% over the following quarter), a 37% trim in Q2 2025 (shares rose 83% over the following quarter), a 368% increase in Q4 2025 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 431.00K $4.93M New
Q4 2024 350.00K $1.48M Reduce
Q1 2025 175.00K $378.00K Reduce
Q2 2025 110.00K $242.00K Reduce
Q3 2025 110.00K $442.20K Hold
Q4 2025 515.00K $9.17M Add
Q1 2026 515.00K $11.58M Hold
Q2 2026 407.34K $10.75M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANRO and 13F data

ANRO (ALTO NEUROSCIENCE INC COM SHS) is a Health Care company. 58 other funds we track also report a position in ANRO — the largest reported positions include Alpha Wave Global, LP (US$97.8M), Commodore Capital LP (US$71.9M), PERCEPTIVE ADVISORS LLC (US$42.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANRO

All ANRO fund holders →

FAQ

How long has Ikarian Capital, LLC held ANRO?

Ikarian Capital, LLC has disclosed ANRO holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Ikarian Capital, LLC's current position in ANRO?

As of Q2 2026, Ikarian Capital, LLC holds 407.34K shares of ANRO (ALTO NEUROSCIENCE INC COM SHS), valued at $10.75M, representing 1.73% of its reported portfolio and ranking #16.

Has Ikarian Capital, LLC been buying or selling ANRO?

In the latest 13F filing (Q2 2026), Ikarian Capital, LLC reduced its position in ANRO. The position peaked in Q1 2026 at 515.00K shares.

Which other funds hold ANRO?

Other major institutional holders of ANRO include Alpha Wave Global, LP, Commodore Capital LP, PERCEPTIVE ADVISORS LLC, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.